Abstract
It is unclear whether differences exist in baseline serum galactomannan (sGM) in patients with hematologic malignancies and invasive pulmonary aspergillosis (IPA) caused by non-fumigatus Aspergillus species vs Aspergillus fumigatus. We found no differences in baseline sGM positivity rates, median sGM levels, and 42-day mortality in 72 such patients (Aspergillus fumigatus in 43 and non-fumigatus Aspergillus in 29).
Original language | English (US) |
---|---|
Pages (from-to) | 639-642 |
Number of pages | 4 |
Journal | Medical mycology |
Volume | 57 |
Issue number | 5 |
DOIs | |
State | Published - Jul 2019 |
Keywords
- Aspergillus species
- Galactomannan
- Hematologic malignancies
- Pulmonary aspergillosis
ASJC Scopus subject areas
- Infectious Diseases